|
Volumn 44, Issue 3, 2013, Pages 868-869
|
The use of tissue plasminogen-activator in pregnancy: A taboo treatment or a time to think out of the box
|
Author keywords
Pregnancy; Stroke; T PA
|
Indexed keywords
ALTEPLASE;
UROKINASE;
ABORTION;
ARTICLE;
BIRTH DEFECT;
BLOOD CLOT LYSIS;
BRAIN HEMORRHAGE;
BRAIN INJURY;
BRAIN ISCHEMIA;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL (TOPIC);
FETAL DEMISE;
FETUS;
FETUS DEATH;
FETUS WASTAGE;
FIBRINOLYTIC THERAPY;
HEALTH CARE PERSONNEL;
HEMATOMA;
HUMAN;
MATERNAL MORTALITY;
MEDICOLEGAL ASPECT;
MITOSIS INDEX;
NONHUMAN;
PREGNANCY;
PREMATURE LABOR;
PRENATAL EXPOSURE;
PRIORITY JOURNAL;
RISK;
SIDE EFFECT;
SOLUTIO PLACENTAE;
SPONTANEOUS ABORTION;
TERATOGENICITY;
FEMALE;
FIBRINOLYTIC AGENTS;
HUMANS;
PREGNANCY;
PREGNANCY COMPLICATIONS, CARDIOVASCULAR;
STROKE;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
|
EID: 84876249637
PISSN: 00392499
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/STROKEAHA.111.000677 Document Type: Article |
Times cited : (24)
|
References (3)
|